A multicentre randomised, double-blind, placebo-controlled, dose-ranging study to evaluate once daily doses of AIT-082 over 24 weeks in probable Alzheimer's disease patients. Protocol #082-99-006. (2000–2001)
- Grant type:
- CroMedica Pty Ltd
- Researchers:
-
-
Mayne Professor of Psychiatry
Medical School (Office & AME)Faculty of Medicine
-
- Funded by:
- CroMedica Pty Ltd
